Associate Professor Glen Reid

Map

Selected grants

2014

  • The Sydney Cancer Conference 2014 Bridging Research and Practice - Ian Potter Foundation Conference grant; Yip S, Reid G; Ian Potter Foundation/Travel Support.

2012

  • The use of RNAi to identify new therapeutic targets for malignant mesothelioma; Reid G; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

2010

  • The Lunar PIXImus II DEXA Scanner; Zhou H, Seibel M, Handelsman D, Le Couteur D, Nicholson G, Clarke S, Robertson G, van Zandwijk N, Freedman B, Kennerson M, Allan C, Walters K, Cogger V, Blair I, Reid G, Simanainen U; National Health and Medical Research Council (NHMRC)/Equipment Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Maher, S., Bibby, B., Moody, H., Reid, G. (2015). MicroRNAs and Cancer. In Steven G. Gray (Eds.), Epigenetic Cancer Therapy, (pp. 67-90). London: Academic Press. [More Information]

Journals

  • Vafaee, F., Diakos, C., Kirschner, M., Reid, G., Michael, M., Horvath, L., Alinejad-Rokny, H., Cheng, Z., Kuncic, Z., Clarke, S. (2018). A data-driven, knowledge-based approach to biomarker discovery: application to circulating microRNA markers of colorectal cancer prognosis. Npj Systems Biology And Applications, 4, 20. [More Information]
  • Schelch, K., Kirschner, M., Williams, M., Cheng, Y., van Zandwijk, N., Grusch, M., Reid, G. (2018). A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in Mesothelioma. Molecular Oncology, 12(1), 58-73. [More Information]
  • Ahmadzada, T., Kao, S., Reid, G., Boyer, M., Mahar, A., Cooper, W. (2018). An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer. Journal of Clinical Medicine, 7(6), E153. [More Information]
  • Rath, E., Cheng, Y., Pinese, M., Sarun, K., Hudson, A., Weir, C., Wang, Y., Hakansson, A., Howell, V., Liu, G., Reid, G., Church, W., et al (2018). BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state. PloS One, 13(8), 1-32. [More Information]
  • Ahmadzada, T., Reid, G., Kao, S. (2018). Biomarkers in malignant pleural mesothelioma: current status and future directions. Journal of Thoracic Disease, 10(Suppl 9), S1003-S1007. [More Information]
  • Johnson, T., Schelch, K., Cheng, Y., Williams, M., Sarun, K., Kirschner, M., Kao, S., Linton, A., Klebe, S., McCaughan, B., Lin, R., van Zandwijk, N., Reid, G., et al (2018). Dysregulated expression of the microRNA miR-137 and its target YB-1 contribute to the invasive characteristics of malignant pleural mesothelioma. Journal of Thoracic Oncology, 13(2), 258-272. [More Information]
  • Schelch, K., Wagner, C., Hager, S., Pirker, C., Siess, K., Lang, E., Lin, R., Kirschner, M., Mohr, T., Brcic, L., Reid, G., van Zandwijk, N., et al (2018). FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal. Carcinogenesis, 39(4), 534-545. [More Information]
  • Ahmadzada, T., Reid, G., McKenzie, D. (2018). Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer. Biophysical Reviews, 10(1), 69-86. [More Information]
  • van Zandwijk, N., McDiarmid, J., Brahmbhatt, H., Reid, G. (2018). Response to "An innovative mesothelioma treatment based on mir-16 mimic loaded EGFR targeted minicells (TargomiRs)". Translational Lung Cancer Research, 7(Supp 1), S60-S61. [More Information]
  • Robb, T., Reid, G., Blenkiron, C. (2017). Exploiting microRNAs As Cancer Therapeutics. Targeted Oncology, 12(2), 163-178. [More Information]
  • Williams, M., Cheng, Y., Blenkiron, C., Reid, G. (2017). Exploring Mechanisms of MicroRNA Downregulation in Cancer. MicroRNA, 1(6), 2-16.
  • Kresoja-Rakic, J., Sulemani, M., Kirschner, M., Ronner, M., Reid, G., Kao, S., Schwaller, B., Weder, W., Stahel, R., Felley-Bosco, E. (2017). Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma. Frontiers in Genetics, 8(70), 1-12. [More Information]
  • van Zandwijk, N., Pavlakis, N., Kao, S., Linton, A., Boyer, M., Clarke, S., Huynh, Y., Chrzanowska, A., Fulham, M., Bailey, D., Cooper, W., Kritharides, L., Reid, G., et al (2017). Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study. The Lancet Oncology, 18(10), 1386-1396. [More Information]
  • Cheng, Y., Mok, E., Tan, S., Leygo, C., McLaughlin, C., George, A., Reid, G. (2017). SFRP Tumour Suppressor Genes Are Potential Plasma-Based Epigenetic Biomarkers for Malignant Pleural Mesothelioma. Disease Markers, 2017, 1-10. [More Information]
  • Winata, P., Williams, M., McGowan, E., Nassif, N., van Zandwijk, N., Reid, G. (2017). The analysis of novel microRNA mimic sequences in cancer cells reveals lack of specificity in stem-loop RT-qPCR-based microRNA detection. BMC Research Notes, 10(1), 1-7. [More Information]
  • Kao, S., Cheng, Y., Williams, M., Kirschner, M., Madore, J., Lum, T., Sarun, K., Linton, A., McCaughan, B., Klebe, S., van Zandwijk, N., Scolyer, R., Boyer, M., Cooper, W., Reid, G. (2017). Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 12(9), 1421-1433. [More Information]
  • Kao, S., Kirschner, M., Cooper, W., Tran, T., Burgers, S., Wright, C., Korse, T., van den Broek, D., Edelman, J., Vallely, M., McCaughan, B., Pavlakis, N., Clarke, S., van Zandwijk, N., Reid, G., et al (2016). A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma. British Journal of Cancer, 114(5), 524-531. [More Information]
  • Hoda, M., Dong, Y., Rozsas, A., Klikovits, T., Laszlo, V., Ghanim, B., Stockhammer, P., Ozsvar, J., Jakopovic, M., Reid, G., van Zandwijk, N., et al (2016). Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study. European Journal of Cancer, 63, 64-73. [More Information]
  • Reid, G., Kao, S., Pavlakis, N., Brahmbhatt, H., MacDiarmid, J., Clarke, S., Boyer, M., van Zandwijk, N. (2016). Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer. Epigenomics, 8(8), 1079-1085. [More Information]
  • Cheng, Y., Wright, C., Kirschner, M., Williams, M., Sarun, K., Sytnyk, V., Leshchynska, I., Edelman, J., Vallely, M., McCaughan, B., van Zandwijk, N., Reid, G., et al (2016). KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma. Molecular Cancer, 15(1), 1-12. [More Information]
  • Lin, R., Kirschner, M., Cheng, Y., van Zandwijk, N., Reid, G. (2016). MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients. Genomics Data, 9, 44-49. [More Information]
  • van Zandwijk, N., Soeberg, M., Reid, G. (2016). Using a multidisciplinary approach to combat the burden of asbestos-related disease. Medical Journal of Australia, 204(2), 52-52.e1. [More Information]
  • Kao, S., Fulham, M., Wong, K., Cooper, W., Brahmbhatt, H., MacDiarmid, J., Pattison, S., Sagong, J., Huynh, Y., Leslie, F., Pavlakis, N., Clarke, S., Boyer, M., Reid, G., van Zandwijk, N. (2015). A significant metabolic and radiological response after a novel targeted microRNA-based treatment approach in malignant pleural mesothelioma. American Journal of Respiratory and Critical Care Medicine, 191(12), 1467-1469. [More Information]
  • Klebe, S., Griggs, K., Cheng, Y., Driml, J., Henderson, D., Reid, G. (2015). Blockade of aquaporin 1 inhibits proliferation, motility, and metastatic potential of mesothelioma in vitro but not in an in vivo model. Disease Markers, 2015, 1-9. [More Information]
  • Kirschner, M., Emily, P., Hoda, M., Rozsas, A., Griggs, K., Cheng, Y., Edelman, J., Kao, S., Hyland, R., Dong, Y., Vallely, M., van Zandwijk, N., Reid, G., et al (2015). Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis. British Journal of Cancer, 113(6), 963-969. [More Information]
  • Birnie, K., Yip, Y., Ng, D., Kirschner, M., Reid, G., Prele, C., Musk, A., Lee, Y., Thompson, P., Mutsaers, S., et al (2015). Loss of mir-223 and JNK Signalling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma. Molecular Cancer Research, 13(7), 1106-1118. [More Information]
  • Lin, R., van Zandwijk, N., Reid, G. (2015). MicroRNA Therapeutics � Back in Vogue? Journal of Investigative Genomics, 2(1), 12.
  • Glover, A., Zhao, J., Gill, A., Weiss, J., Mugridge, N., Kim, E., Feeney, A., Ip, J., Reid, G., Clarke, S., Robinson, B., Sidhu, S., et al (2015). microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma. Oncotarget, 6(34), 36675-36688. [More Information]
  • Reid, G. (2015). MicroRNAs in mesothelioma: From tumour suppressors and biomarkers to therapeutic targets. Journal of Thoracic Disease, 7(6), 1031-1040. [More Information]
  • Williams, M., Kirschner, M., Cheng, Y., Hanh, J., Weiss, J., Amaro-Mugridge, N., Wright, C., Linton, A., Kao, S., Edelman, J., Vallely, M., Cooper, W., van Zandwijk, N., Reid, G., et al (2015). miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma. Oncotarget, 6(27), 23480-23495. [More Information]
  • Kirschner, M., Cheng, Y., Armstrong, N., Lin, R., Kao, S., Linton, A., Klebe, S., McCaughan, B., van Zandwijk, N., Reid, G. (2015). MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma. Molecular Oncology, 9(3), 715-726. [More Information]
  • Linton, A., Cheng, Y., Griggs, K., Kirschner, M., Gattani, S., Srikaran, S., Kao, S., McCaughan, B., Klebe, S., van Zandwijk, N., Reid, G. (2014). An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma. British Journal of Cancer, 110(2), 510-519. [More Information]
  • Cheng, N., van Zandwijk, N., Reid, G. (2014). Cilengitide Inhibits Attachment and Invasion of Malignant Pleural Mesothelioma Cells through Antagonism of Integrins αvβ3 and αvβ5. PloS One, 9(3), 1-10. [More Information]
  • Kirschner, M., van Zandwijk, N., Reid, G. (2013). Cell-free microRNAs: potential biomarkers in need of standardized reporting. Frontiers in Genetics, 4, 1-5. [More Information]
  • Henderson, D., Reid, G., Kao, S., Van Zandwijk, N., Klebe, S. (2013). Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA. Journal of Clinical Pathology, 66(10), 854-861. [More Information]
  • Henderson, D., Reid, G., Kao, S., Van Zandwijk, N., Klebe, S. (2013). Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers. Journal of Clinical Pathology, 66(10), 847-853. [More Information]
  • Wright, C., Kirschner, M., Cheng, Y., O’Byrne, K., Gray, S., Schelch, K., Hoda, M., Klebe, S., McCaughan, B., van Zandwijk, N., Reid, G. (2013). Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM). PloS One, 8(8), 1-12. [More Information]
  • Lim, C., Prele, C., Cheah, H., Cheng, Y., Klebe, S., Reid, G., Watkins, D., Baltic, S., Thompson, P., Mutsaers, S. (2013). Mutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant Mesothelioma. PloS One, 8(6), 1-12. [More Information]
  • Reid, G., Pel, M., Kirschner, M., Cheng, Y., Amaro-Mugridge, N., Madrid-Weiss, J., Williams, M., Wright, C., Edelman, J., Vallely, M., van Zandwijk, N., et al (2013). Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma. Annals of Oncology, 24(12), 3128-3135. [More Information]
  • Kirschner, M., Edelman, J., Kao, S., Vallely, M., van Zandwijk, N., Reid, G. (2013). The Impact of Hemolysis on Cell-Free microRNA Biomarkers. Frontiers in Genetics, 4, 1-13. [More Information]
  • Cheng, Y., Kirschner, M., Cheng, N., Gattani, S., Klebe, S., Edelman, J., Vallely, M., McCaughan, B., Jin, H., van Zandwijk, N., Reid, G. (2013). ZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 8(10), 1317-1328. [More Information]
  • Kirschner, M., Cheng, Y., Badrian, B., Kao, S., Creaney, J., Edelman, J., Armstrong, N., Vallely, M., Musk, A., Robinson, B., McCaughan, B., van Zandwijk, N., Reid, G., et al (2012). Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 7(7), 1184-1191. [More Information]
  • Linton, A., van Zandwijk, N., Reid, G., Clarke, S., Cao, C., Kao, S. (2012). Inflammation in malignant mesothelioma - friend or foe? Annals of Cardiothoracic Surgery, 1(4), 516-522. [More Information]
  • van Zandwijk, N., Reid, G., Linton, A., Kao, S. (2012). Radical surgery for malignant pleural mesothelioma: have we identified the appropriate selection tools? Annals of Cardiothoracic Surgery, 1(4), 481-486. [More Information]
  • Lasham, A., Samuel, W., Cao, H., Patel, R., Mehta, R., Stern, J., Reid, G., Woolley, A., Miller, L., Black, M., Braithwaite, A., et al (2012). YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth. Journal of the National Cancer Institute, 104(2), 133-46. [More Information]
  • Reid, G., Kirschner, M., van Zandwijk, N. (2011). Circulating microRNAs: Association with disease and potential use as biomarkers. Critical Reviews in Oncology/Hematology, 80(2), 193-208. [More Information]
  • Kirschner, M., Kao, S., Edelman, J., Armstrong, N., Vallely, M., van Zandwijk, N., Reid, G. (2011). Haemolysis during Sample Preparation Alters microRNA Content of Plasma. PloS One, 6(9), 1-9. [More Information]
  • Kao, S., Klebe, S., Henderson, D., Reid, G., Chatfield, M., Armstrong, N., Yan, T., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011). Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology, 6(11), 1923-1929. [More Information]
  • Kao, S., Reid, G., van Zandwijk, N., Henderson, D., Klebe, S. (2011). Molecular biomarkers in malignant mesothelioma: state of the art. Pathology, 43(3), 201-212. [More Information]
  • Herbert, M., Coppieters 't Wallant, N., Lasham, A., Cao, H., Reid, G. (2011). The importance of RT-qPCR primer design for the detection of siRNA-mediated mRNA silencing. BMC Research Notes, 4(Article 148), 1-7. [More Information]
  • Kao, S., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Reid, G., Burn, J., McCaughan, B., Henderson, D., et al (2011). Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology, 43(2), 128-132. [More Information]
  • Lasham, A., Herbert, M., Coppieters 't Wallant, N., Patel, R., Feng, S., Eszes, M., Cao, H., Reid, G. (2010). A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5' RACE and a molecular beacon probe. Nucleic Acids Research, 38(3), e19 - 1-e19 - 11. [More Information]
  • Li, Y., Revalde, J., Reid, G., Paxton, J. (2010). Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer. Drug Metabolism Reviews, 42(4), 590-611. [More Information]
  • Li, Y., Revalde, J., Reid, G., Paxton, J. (2010). Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. Cancer Chemotherapy and Pharmacology. [More Information]

2018

  • Vafaee, F., Diakos, C., Kirschner, M., Reid, G., Michael, M., Horvath, L., Alinejad-Rokny, H., Cheng, Z., Kuncic, Z., Clarke, S. (2018). A data-driven, knowledge-based approach to biomarker discovery: application to circulating microRNA markers of colorectal cancer prognosis. Npj Systems Biology And Applications, 4, 20. [More Information]
  • Schelch, K., Kirschner, M., Williams, M., Cheng, Y., van Zandwijk, N., Grusch, M., Reid, G. (2018). A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in Mesothelioma. Molecular Oncology, 12(1), 58-73. [More Information]
  • Ahmadzada, T., Kao, S., Reid, G., Boyer, M., Mahar, A., Cooper, W. (2018). An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer. Journal of Clinical Medicine, 7(6), E153. [More Information]
  • Rath, E., Cheng, Y., Pinese, M., Sarun, K., Hudson, A., Weir, C., Wang, Y., Hakansson, A., Howell, V., Liu, G., Reid, G., Church, W., et al (2018). BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state. PloS One, 13(8), 1-32. [More Information]
  • Ahmadzada, T., Reid, G., Kao, S. (2018). Biomarkers in malignant pleural mesothelioma: current status and future directions. Journal of Thoracic Disease, 10(Suppl 9), S1003-S1007. [More Information]
  • Johnson, T., Schelch, K., Cheng, Y., Williams, M., Sarun, K., Kirschner, M., Kao, S., Linton, A., Klebe, S., McCaughan, B., Lin, R., van Zandwijk, N., Reid, G., et al (2018). Dysregulated expression of the microRNA miR-137 and its target YB-1 contribute to the invasive characteristics of malignant pleural mesothelioma. Journal of Thoracic Oncology, 13(2), 258-272. [More Information]
  • Schelch, K., Wagner, C., Hager, S., Pirker, C., Siess, K., Lang, E., Lin, R., Kirschner, M., Mohr, T., Brcic, L., Reid, G., van Zandwijk, N., et al (2018). FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal. Carcinogenesis, 39(4), 534-545. [More Information]
  • Ahmadzada, T., Reid, G., McKenzie, D. (2018). Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer. Biophysical Reviews, 10(1), 69-86. [More Information]
  • van Zandwijk, N., McDiarmid, J., Brahmbhatt, H., Reid, G. (2018). Response to "An innovative mesothelioma treatment based on mir-16 mimic loaded EGFR targeted minicells (TargomiRs)". Translational Lung Cancer Research, 7(Supp 1), S60-S61. [More Information]

2017

  • Robb, T., Reid, G., Blenkiron, C. (2017). Exploiting microRNAs As Cancer Therapeutics. Targeted Oncology, 12(2), 163-178. [More Information]
  • Williams, M., Cheng, Y., Blenkiron, C., Reid, G. (2017). Exploring Mechanisms of MicroRNA Downregulation in Cancer. MicroRNA, 1(6), 2-16.
  • Kresoja-Rakic, J., Sulemani, M., Kirschner, M., Ronner, M., Reid, G., Kao, S., Schwaller, B., Weder, W., Stahel, R., Felley-Bosco, E. (2017). Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma. Frontiers in Genetics, 8(70), 1-12. [More Information]
  • van Zandwijk, N., Pavlakis, N., Kao, S., Linton, A., Boyer, M., Clarke, S., Huynh, Y., Chrzanowska, A., Fulham, M., Bailey, D., Cooper, W., Kritharides, L., Reid, G., et al (2017). Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study. The Lancet Oncology, 18(10), 1386-1396. [More Information]
  • Cheng, Y., Mok, E., Tan, S., Leygo, C., McLaughlin, C., George, A., Reid, G. (2017). SFRP Tumour Suppressor Genes Are Potential Plasma-Based Epigenetic Biomarkers for Malignant Pleural Mesothelioma. Disease Markers, 2017, 1-10. [More Information]
  • Winata, P., Williams, M., McGowan, E., Nassif, N., van Zandwijk, N., Reid, G. (2017). The analysis of novel microRNA mimic sequences in cancer cells reveals lack of specificity in stem-loop RT-qPCR-based microRNA detection. BMC Research Notes, 10(1), 1-7. [More Information]
  • Kao, S., Cheng, Y., Williams, M., Kirschner, M., Madore, J., Lum, T., Sarun, K., Linton, A., McCaughan, B., Klebe, S., van Zandwijk, N., Scolyer, R., Boyer, M., Cooper, W., Reid, G. (2017). Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 12(9), 1421-1433. [More Information]

2016

  • Kao, S., Kirschner, M., Cooper, W., Tran, T., Burgers, S., Wright, C., Korse, T., van den Broek, D., Edelman, J., Vallely, M., McCaughan, B., Pavlakis, N., Clarke, S., van Zandwijk, N., Reid, G., et al (2016). A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma. British Journal of Cancer, 114(5), 524-531. [More Information]
  • Hoda, M., Dong, Y., Rozsas, A., Klikovits, T., Laszlo, V., Ghanim, B., Stockhammer, P., Ozsvar, J., Jakopovic, M., Reid, G., van Zandwijk, N., et al (2016). Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study. European Journal of Cancer, 63, 64-73. [More Information]
  • Reid, G., Kao, S., Pavlakis, N., Brahmbhatt, H., MacDiarmid, J., Clarke, S., Boyer, M., van Zandwijk, N. (2016). Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer. Epigenomics, 8(8), 1079-1085. [More Information]
  • Cheng, Y., Wright, C., Kirschner, M., Williams, M., Sarun, K., Sytnyk, V., Leshchynska, I., Edelman, J., Vallely, M., McCaughan, B., van Zandwijk, N., Reid, G., et al (2016). KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma. Molecular Cancer, 15(1), 1-12. [More Information]
  • Lin, R., Kirschner, M., Cheng, Y., van Zandwijk, N., Reid, G. (2016). MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients. Genomics Data, 9, 44-49. [More Information]
  • van Zandwijk, N., Soeberg, M., Reid, G. (2016). Using a multidisciplinary approach to combat the burden of asbestos-related disease. Medical Journal of Australia, 204(2), 52-52.e1. [More Information]

2015

  • Kao, S., Fulham, M., Wong, K., Cooper, W., Brahmbhatt, H., MacDiarmid, J., Pattison, S., Sagong, J., Huynh, Y., Leslie, F., Pavlakis, N., Clarke, S., Boyer, M., Reid, G., van Zandwijk, N. (2015). A significant metabolic and radiological response after a novel targeted microRNA-based treatment approach in malignant pleural mesothelioma. American Journal of Respiratory and Critical Care Medicine, 191(12), 1467-1469. [More Information]
  • Klebe, S., Griggs, K., Cheng, Y., Driml, J., Henderson, D., Reid, G. (2015). Blockade of aquaporin 1 inhibits proliferation, motility, and metastatic potential of mesothelioma in vitro but not in an in vivo model. Disease Markers, 2015, 1-9. [More Information]
  • Kirschner, M., Emily, P., Hoda, M., Rozsas, A., Griggs, K., Cheng, Y., Edelman, J., Kao, S., Hyland, R., Dong, Y., Vallely, M., van Zandwijk, N., Reid, G., et al (2015). Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis. British Journal of Cancer, 113(6), 963-969. [More Information]
  • Birnie, K., Yip, Y., Ng, D., Kirschner, M., Reid, G., Prele, C., Musk, A., Lee, Y., Thompson, P., Mutsaers, S., et al (2015). Loss of mir-223 and JNK Signalling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma. Molecular Cancer Research, 13(7), 1106-1118. [More Information]
  • Lin, R., van Zandwijk, N., Reid, G. (2015). MicroRNA Therapeutics � Back in Vogue? Journal of Investigative Genomics, 2(1), 12.
  • Glover, A., Zhao, J., Gill, A., Weiss, J., Mugridge, N., Kim, E., Feeney, A., Ip, J., Reid, G., Clarke, S., Robinson, B., Sidhu, S., et al (2015). microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma. Oncotarget, 6(34), 36675-36688. [More Information]
  • Maher, S., Bibby, B., Moody, H., Reid, G. (2015). MicroRNAs and Cancer. In Steven G. Gray (Eds.), Epigenetic Cancer Therapy, (pp. 67-90). London: Academic Press. [More Information]
  • Reid, G. (2015). MicroRNAs in mesothelioma: From tumour suppressors and biomarkers to therapeutic targets. Journal of Thoracic Disease, 7(6), 1031-1040. [More Information]
  • Williams, M., Kirschner, M., Cheng, Y., Hanh, J., Weiss, J., Amaro-Mugridge, N., Wright, C., Linton, A., Kao, S., Edelman, J., Vallely, M., Cooper, W., van Zandwijk, N., Reid, G., et al (2015). miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma. Oncotarget, 6(27), 23480-23495. [More Information]
  • Kirschner, M., Cheng, Y., Armstrong, N., Lin, R., Kao, S., Linton, A., Klebe, S., McCaughan, B., van Zandwijk, N., Reid, G. (2015). MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma. Molecular Oncology, 9(3), 715-726. [More Information]

2014

  • Linton, A., Cheng, Y., Griggs, K., Kirschner, M., Gattani, S., Srikaran, S., Kao, S., McCaughan, B., Klebe, S., van Zandwijk, N., Reid, G. (2014). An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma. British Journal of Cancer, 110(2), 510-519. [More Information]
  • Cheng, N., van Zandwijk, N., Reid, G. (2014). Cilengitide Inhibits Attachment and Invasion of Malignant Pleural Mesothelioma Cells through Antagonism of Integrins αvβ3 and αvβ5. PloS One, 9(3), 1-10. [More Information]

2013

  • Kirschner, M., van Zandwijk, N., Reid, G. (2013). Cell-free microRNAs: potential biomarkers in need of standardized reporting. Frontiers in Genetics, 4, 1-5. [More Information]
  • Henderson, D., Reid, G., Kao, S., Van Zandwijk, N., Klebe, S. (2013). Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA. Journal of Clinical Pathology, 66(10), 854-861. [More Information]
  • Henderson, D., Reid, G., Kao, S., Van Zandwijk, N., Klebe, S. (2013). Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers. Journal of Clinical Pathology, 66(10), 847-853. [More Information]
  • Wright, C., Kirschner, M., Cheng, Y., O’Byrne, K., Gray, S., Schelch, K., Hoda, M., Klebe, S., McCaughan, B., van Zandwijk, N., Reid, G. (2013). Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM). PloS One, 8(8), 1-12. [More Information]
  • Lim, C., Prele, C., Cheah, H., Cheng, Y., Klebe, S., Reid, G., Watkins, D., Baltic, S., Thompson, P., Mutsaers, S. (2013). Mutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant Mesothelioma. PloS One, 8(6), 1-12. [More Information]
  • Reid, G., Pel, M., Kirschner, M., Cheng, Y., Amaro-Mugridge, N., Madrid-Weiss, J., Williams, M., Wright, C., Edelman, J., Vallely, M., van Zandwijk, N., et al (2013). Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma. Annals of Oncology, 24(12), 3128-3135. [More Information]
  • Kirschner, M., Edelman, J., Kao, S., Vallely, M., van Zandwijk, N., Reid, G. (2013). The Impact of Hemolysis on Cell-Free microRNA Biomarkers. Frontiers in Genetics, 4, 1-13. [More Information]
  • Cheng, Y., Kirschner, M., Cheng, N., Gattani, S., Klebe, S., Edelman, J., Vallely, M., McCaughan, B., Jin, H., van Zandwijk, N., Reid, G. (2013). ZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 8(10), 1317-1328. [More Information]

2012

  • Kirschner, M., Cheng, Y., Badrian, B., Kao, S., Creaney, J., Edelman, J., Armstrong, N., Vallely, M., Musk, A., Robinson, B., McCaughan, B., van Zandwijk, N., Reid, G., et al (2012). Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma. Journal of Thoracic Oncology, 7(7), 1184-1191. [More Information]
  • Linton, A., van Zandwijk, N., Reid, G., Clarke, S., Cao, C., Kao, S. (2012). Inflammation in malignant mesothelioma - friend or foe? Annals of Cardiothoracic Surgery, 1(4), 516-522. [More Information]
  • van Zandwijk, N., Reid, G., Linton, A., Kao, S. (2012). Radical surgery for malignant pleural mesothelioma: have we identified the appropriate selection tools? Annals of Cardiothoracic Surgery, 1(4), 481-486. [More Information]
  • Lasham, A., Samuel, W., Cao, H., Patel, R., Mehta, R., Stern, J., Reid, G., Woolley, A., Miller, L., Black, M., Braithwaite, A., et al (2012). YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth. Journal of the National Cancer Institute, 104(2), 133-46. [More Information]

2011

  • Reid, G., Kirschner, M., van Zandwijk, N. (2011). Circulating microRNAs: Association with disease and potential use as biomarkers. Critical Reviews in Oncology/Hematology, 80(2), 193-208. [More Information]
  • Kirschner, M., Kao, S., Edelman, J., Armstrong, N., Vallely, M., van Zandwijk, N., Reid, G. (2011). Haemolysis during Sample Preparation Alters microRNA Content of Plasma. PloS One, 6(9), 1-9. [More Information]
  • Kao, S., Klebe, S., Henderson, D., Reid, G., Chatfield, M., Armstrong, N., Yan, T., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011). Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology, 6(11), 1923-1929. [More Information]
  • Kao, S., Reid, G., van Zandwijk, N., Henderson, D., Klebe, S. (2011). Molecular biomarkers in malignant mesothelioma: state of the art. Pathology, 43(3), 201-212. [More Information]
  • Herbert, M., Coppieters 't Wallant, N., Lasham, A., Cao, H., Reid, G. (2011). The importance of RT-qPCR primer design for the detection of siRNA-mediated mRNA silencing. BMC Research Notes, 4(Article 148), 1-7. [More Information]
  • Kao, S., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Reid, G., Burn, J., McCaughan, B., Henderson, D., et al (2011). Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology, 43(2), 128-132. [More Information]

2010

  • Lasham, A., Herbert, M., Coppieters 't Wallant, N., Patel, R., Feng, S., Eszes, M., Cao, H., Reid, G. (2010). A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5' RACE and a molecular beacon probe. Nucleic Acids Research, 38(3), e19 - 1-e19 - 11. [More Information]
  • Li, Y., Revalde, J., Reid, G., Paxton, J. (2010). Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer. Drug Metabolism Reviews, 42(4), 590-611. [More Information]
  • Li, Y., Revalde, J., Reid, G., Paxton, J. (2010). Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. Cancer Chemotherapy and Pharmacology. [More Information]

To update your profile click here. For support on your academic profile contact .